Garudon Medical Systems Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 28-12-2024
- Paid Up Capital ₹ 0.10 M
as on 28-12-2024
- Company Age 15 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -62.39%
(FY 2020)
- Profit -88.02%
(FY 2020)
- Ebitda -38.81%
(FY 2020)
- Net Worth 2.25%
(FY 2020)
- Total Assets 46.45%
(FY 2020)
About Garudon Medical Systems
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ellappan Vadivelan and Subramaniam Geetha serve as directors at the Company.
- CIN/LLPIN
U52310TN2009PTC073137
- Company No.
073137
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Oct 2009
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Garudon Medical Systems Private Limited offer?
Garudon Medical Systems Private Limited offers a wide range of products and services, including Diagnostic Medical Imaging Equipment, CT Scan Machine, Medical Imaging Machine & Accessories, Repair & Maintenance Services, Machinery Repairs, Canon CT Scanner, Mammogram Machine, MRI Machine, Hitachi MRI Machine.
Who are the key members and board of directors at Garudon Medical Systems?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ellappan Vadivelan  | Director | 09-Oct-2009 | Current |
| Subramaniam Geetha | Director | 27-Dec-2021 | Current |
Financial Performance of Garudon Medical Systems.
Garudon Medical Systems Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 62.39% decrease. The company also saw a substantial fall in profitability, with a 88.02% decrease in profit. The company's net worth moved up by a moderate rise of 2.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Garudon Medical Systems?
In 2018, Garudon Medical Systems had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Garudon Medical Systems?
Unlock and access historical data on people associated with Garudon Medical Systems, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Garudon Medical Systems, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Garudon Medical Systems's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
